387 related articles for article (PubMed ID: 11025724)
1. Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms.
Araki I; Kitahara M; Oida T; Kuno S
J Urol; 2000 Nov; 164(5):1640-3. PubMed ID: 11025724
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic Parkinson's disease patients at the urologic clinic.
Ragab MM; Mohammed ES
Neurourol Urodyn; 2011 Sep; 30(7):1258-61. PubMed ID: 21404318
[TBL] [Abstract][Full Text] [Related]
3. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings.
Nitti VW; Kim Y; Combs AJ
J Urol; 1997 Feb; 157(2):600-3. PubMed ID: 8996367
[TBL] [Abstract][Full Text] [Related]
4. Value of routine evaluation of the voiding phase when performing urodynamic testing in women with lower urinary tract symptoms.
Carlson KV; Fiske J; Nitti VW
J Urol; 2000 Nov; 164(5):1614-8. PubMed ID: 11025717
[TBL] [Abstract][Full Text] [Related]
5. Lower urinary tract symptoms in young men: videourodynamic findings and correlation with noninvasive measures.
Nitti VW; Lefkowitz G; Ficazzola M; Dixon CM
J Urol; 2002 Jul; 168(1):135-8. PubMed ID: 12050507
[TBL] [Abstract][Full Text] [Related]
6. The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis.
Kim YH; Goodman C; Omessi E; Rivera V; Kattan MW; Boone TB
J Urol; 1998 Mar; 159(3):972-6. PubMed ID: 9474196
[TBL] [Abstract][Full Text] [Related]
7. Relationship of bladder dysfunction to lesion site in multiple sclerosis.
Araki I; Matsui M; Ozawa K; Takeda M; Kuno S
J Urol; 2003 Apr; 169(4):1384-7. PubMed ID: 12629367
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional voiding in women.
Carlson KV; Rome S; Nitti VW
J Urol; 2001 Jan; 165(1):143-7; discussion 147-8. PubMed ID: 11125384
[TBL] [Abstract][Full Text] [Related]
9. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease.
Finazzi-Agrò E; Peppe A; D'Amico A; Petta F; Mazzone P; Stanzione P; Micali F; Caltagirone C
J Urol; 2003 Apr; 169(4):1388-91. PubMed ID: 12629368
[TBL] [Abstract][Full Text] [Related]
10. Lower urinary tract dysfunction in Machado-Joseph disease: a study of 11 clinical-urodynamic observations.
Sakakibara R; Uchiyama T; Arai K; Yamanishi T; Hattori T
J Neurol Sci; 2004 Mar; 218(1-2):67-72. PubMed ID: 14759635
[TBL] [Abstract][Full Text] [Related]
11. Urodynamic analysis and treatment of male Parkinson's disease patients with voiding dysfunction.
Xue P; Wang T; Zong H; Zhang Y
Chin Med J (Engl); 2014; 127(5):878-81. PubMed ID: 24571881
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
[TBL] [Abstract][Full Text] [Related]
13. Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects.
Bonnet AM; Pichon J; Vidailhet M; Gouider-Khouja N; Robain G; Perrigot M; Agid Y
Mov Disord; 1997 Jul; 12(4):509-13. PubMed ID: 9251068
[TBL] [Abstract][Full Text] [Related]
14. Significant correlation of the American Urological Association symptom score and a novel urodynamic parameter: detrusor contraction duration.
Kaplan SA; Reis RB
J Urol; 1996 Nov; 156(5):1668-72. PubMed ID: 8863567
[TBL] [Abstract][Full Text] [Related]
15. Preoperative urodynamic evaluation may predict voiding dysfunction in women undergoing pubovaginal sling.
Miller EA; Amundsen CL; Toh KL; Flynn BJ; Webster GD
J Urol; 2003 Jun; 169(6):2234-7. PubMed ID: 12771757
[TBL] [Abstract][Full Text] [Related]
16. Use of novel urodynamic parameters, detrusor contraction duration and detrusor contraction index, in men with lower urinary tract symptoms.
Turner CD; Kuznetsov D; Contreras BA; Gerber GS
Tech Urol; 1998 Sep; 4(3):136-40. PubMed ID: 9800891
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and mechanism of bladder dysfunction in Guillain-Barré Syndrome.
Sakakibara R; Uchiyama T; Kuwabara S; Mori M; Ito T; Yamamoto T; Awa Y; Yamaguchi C; Yuki N; Vernino S; Kishi M; Shirai K
Neurourol Urodyn; 2009; 28(5):432-7. PubMed ID: 19260087
[TBL] [Abstract][Full Text] [Related]
18. [Effects of deep brain stimulation on urodynamic findings in patients with Parkinson's disease].
Shimizu N; Matsumoto S; Mori Y; Yoshioka N; Uemura H; Nakano N; Taneda M
Hinyokika Kiyo; 2007 Sep; 53(9):609-12. PubMed ID: 17933134
[TBL] [Abstract][Full Text] [Related]
19. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
20. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
Kuo HC
Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
